Agents and Actions 1991-09-01

New highly potent bradykinin B2 receptor antagonists.

D Regoli, N E Rhaleb, C Tousignant, N Rouissi, F Nantel, D Jukic, G Drapeau

Index: Agents Actions 34 , 138-141, (1991)

Full Text: HTML

Abstract

pA2 values of new B2 receptor antagonists ranging from 7.51 to 8.86 were measured on the rabbit jugular vein, while lower values were observed in the other preparations (for instance, the hamster urinary bladder). The most potent antagonists were those containing a hydroxyproline (Hyp) in position 3, a D-Arg at the N-terminal and a Leu instead of a Phe in position 8, with or without other chemical changes. D-Arg[Hyp3,D-Phe7,Leu8]-BK was found to be competitive, selective for B2 receptors and specific for kinins since it was without effect against substance P and angiotensin II in the rabbit jugular vein. The essential feature for obtaining B2 receptor antagonists appears to be the replacement or reorientation of Phe8 of bradykinin. The rabbit jugular vein provides a sensitive bioassay in which the potency and specificity of B2 receptor antagonists can be adequately evaluated.


Related Compounds

Related Articles:

Non-selectivity of new bradykinin antagonists for B1 receptors.

1992-01-01

[Life Sci. 51 , PL 125, (1992)]

A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.

1992-05-01

[J. Med. Chem. 35 , 1563, (1992)]

Pharmacological evidence for a single bradykinin B2 receptor in the guinea-pig.

1995-10-01

[Br. J. Pharmacol. 116(3) , 2106-12, (1995)]

Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin).

1992-01-14

[Eur. J. Pharmacol. 210(2) , 115-20, (1992)]

More Articles...